Unum therapeutics inc. (UMRX)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
Collaboration revenue

26,477

22,499

11,016

12,039

10,567

9,734

0

0

0

-

0

0

-

Collaboration revenue

-

-

-

-

-

-

-

-

-

-

-

-

0

Operating expenses:
Research and development

40,804

43,709

44,120

44,037

42,546

38,285

35,082

33,007

31,022

29,832

0

0

0

General and administrative

12,151

10,968

10,318

9,964

8,881

7,454

6,851

5,808

4,800

4,680

0

0

0

Total operating expenses

52,955

54,677

54,438

54,001

51,427

45,739

41,933

38,815

35,822

34,512

0

0

0

Loss from operations

-26,478

-32,178

-43,422

-41,962

-40,860

-36,005

-33,881

-30,475

-27,069

-26,152

0

0

0

Other income (expense):
Interest income

164

267

614

988

1,222

1,153

844

539

377

386

0

0

0

Other income, net

-

-

0

-

-

320

0

0

0

-

0

0

-

Other income, net

-

-

-

-

-

-

-

-

-

-

-

-

0

Total other income (expense), net

242

345

686

981

1,372

1,473

1,265

1,027

781

660

0

0

0

Net loss

-26,236

-31,833

-42,736

-40,981

-39,488

-34,532

-32,616

-29,448

-26,288

-25,492

0

0

0

Accretion of redeemable convertible preferred stock to redemption value

-

-

-

-

-

16

32

48

65

65

0

0

0

Net loss attributable to common stockholders

-

-

-42,736

-40,981

-

-34,548

-32,648

-29,496

-26,353

-25,557

0

0

0

Net loss per common share, basic and diluted

-0.20

0.08

-0.39

-0.34

-0.39

-0.08

-0.34

-0.31

-0.66

-0.66

-0.69

-0.58

-0.58

Weighted average common shares outstanding, basic and diluted

30,136

30,671

30,661

30,505

30,083

30,342

29,879

29,155

10,204

10,194

10,192

10,190

10,190

Comprehensive loss:
Net loss

-26,236

-31,833

-42,736

-40,981

-39,488

-34,532

-32,616

-29,448

-26,288

-25,492

0

0

0

Other comprehensive income (loss):
Unrealized gains on marketable securities, net of tax of $0

-

12

24

13

5

4

0

30

29

8

0

0

0

Total other comprehensive income

-

12

24

13

5

4

0

30

29

8

0

0

0

Comprehensive loss

-26,234

-31,821

-42,712

-40,968

-39,483

-34,528

-32,616

-29,418

-26,259

-25,484

0

0

0